All News #Library
Biotech
Memgen Initiates Phase 1 Combo Trial of MEM-288 with Docetaxel
25 Aug 2025 //
GLOBENEWSWIRE
Memgen Announces Data on MEM-288 in Advanced/Metastatic NSCLC
06 Jun 2023 //
BUSINESSWIRE

Market Place
Sourcing Support